Literature DB >> 9619029

Analysis of lobectomy for small peripheral lung cancer supports extended segmentectomy.

T Sakamoto1, N Tsubota, Y Miyamoto, M Yoshimura.   

Abstract

We reviewed the records of 53 patients who underwent lobectomy for peripheral non-small cell lung cancer under 2 cm in diameter and established a rationale for segmentectomy with intraoperative lymph nodes dissection (extended segmentectomy). Five patients (9.4%) had intrapulmonary metastases. Nodal status was N0 in 34 patients (64.2%), N1 in 7 (13.2%), and N2 in 12 (22.6%). Based on examination of intraoperative frozen sections, 31 patients lacking lymph node metastases and visceral pleural involvement could have been candidates for extended segmentectomy. Twenty-seven had stage I disease on postoperative examination of paraffin-embedded sections. Of the remaining 4 patients, 1 had involvement of intrapulmonary lymph nodes in the segment where the primary lesion originated. Another patient had involvement only at the first mediastinal lymph node level, representing a "skipping metastasis". The remaining 2 patients had no lymph node involvement, but had intrapulmonary metastases in the same segments as the primary lesion. We conclude that an extended segmentectomy may be as effective as lobectomy for treatment of peripheral non-small cell lung cancer under 2 cm in diameter without evident lymph node involvement.

Entities:  

Mesh:

Year:  1998        PMID: 9619029     DOI: 10.1007/bf03217749

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  12 in total

1.  Minimal resection for bronchogenic carcinoma. An update.

Authors:  M M Crabbe; G A Patrissi; L J Fontenelle
Journal:  Chest       Date:  1991-06       Impact factor: 9.410

2.  Segmental resection for lung cancer. A fifteen-year experience.

Authors:  R J Jensik; L P Faber; F J Milloy; D O Monson
Journal:  J Thorac Cardiovasc Surg       Date:  1973-10       Impact factor: 5.209

Review 3.  A new international staging system for lung cancer.

Authors:  C F Mountain
Journal:  Chest       Date:  1986-04       Impact factor: 9.410

4.  Prognosis of undetected intrapulmonary metastases in resected lung cancer.

Authors:  N Shimizu; A Ando; H Date; S Teramoto
Journal:  Cancer       Date:  1993-06-15       Impact factor: 6.860

5.  Survival after conservative resection for T1 N0 M0 non-small cell lung cancer.

Authors:  R C Read; G Yoder; R C Schaeffer
Journal:  Ann Thorac Surg       Date:  1990-03       Impact factor: 4.330

6.  Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: are these carcinomas candidates for video-assisted lobectomy?

Authors:  H Asamura; H Nakayama; H Kondo; R Tsuchiya; Y Shimosato; T Naruke
Journal:  J Thorac Cardiovasc Surg       Date:  1996-06       Impact factor: 5.209

7.  Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma. Five-year survival and patterns of intrathoracic recurrence.

Authors:  W H Warren; L P Faber
Journal:  J Thorac Cardiovasc Surg       Date:  1994-04       Impact factor: 5.209

8.  Most peripheral, node-negative, non-small-cell lung cancers have low proliferative rates and no intratumoral and peritumoral blood and lymphatic vessel invasion. Rationale for treatment with wedge resection alone.

Authors:  P Macchiarini; G Fontanini; J M Hardin; R Pingitore; C A Angeletti
Journal:  J Thorac Cardiovasc Surg       Date:  1992-10       Impact factor: 5.209

9.  Comparison of lobectomy and wedge resection for carcinoma of the lung.

Authors:  T H Hoffmann; H T Ransdell
Journal:  J Thorac Cardiovasc Surg       Date:  1980-02       Impact factor: 5.209

10.  Wedge resection as an alternative procedure for peripheral bronchogenic carcinoma in poor-risk patients.

Authors:  L E Errett; J Wilson; R C Chiu; D D Munro
Journal:  J Thorac Cardiovasc Surg       Date:  1985-11       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.